PL371436A1 - Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych - Google Patents
Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowychInfo
- Publication number
- PL371436A1 PL371436A1 PL03371436A PL37143603A PL371436A1 PL 371436 A1 PL371436 A1 PL 371436A1 PL 03371436 A PL03371436 A PL 03371436A PL 37143603 A PL37143603 A PL 37143603A PL 371436 A1 PL371436 A1 PL 371436A1
- Authority
- PL
- Poland
- Prior art keywords
- prevent
- combination therapy
- steroidal anti
- inflammatory agent
- cardiovascular disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35300802P | 2002-01-30 | 2002-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL371436A1 true PL371436A1 (pl) | 2005-06-13 |
Family
ID=27663163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03371436A PL371436A1 (pl) | 2002-01-30 | 2003-01-30 | Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1469884A1 (pl) |
JP (1) | JP2005521665A (pl) |
KR (1) | KR20040078683A (pl) |
CN (1) | CN1625412A (pl) |
BR (1) | BR0307342A (pl) |
CA (1) | CA2473797A1 (pl) |
MX (1) | MXPA04007128A (pl) |
PL (1) | PL371436A1 (pl) |
WO (1) | WO2003063908A1 (pl) |
ZA (1) | ZA200405829B (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2005112247A (ru) * | 2002-09-25 | 2006-01-20 | Форбз Меди-Тек Инк. (Ca) | Новые структуры и композиции, содержащие стеролы и/или станолы и определенные классы противовоспалительных средств, и их применение для лечения или предупреждения сердечно-сосудистого заболевания, лежащих в его основе состояний, включая гиперлипидемию, и других нарушений, при которых воспаление является частью их этиологии или проявления |
US8487128B2 (en) * | 2002-11-26 | 2013-07-16 | Chs Pharma, Inc. | Protection of normal cells |
WO2006102439A2 (en) | 2005-03-23 | 2006-09-28 | Florida Atlantic University | Treatment or prevention of cancer and precancerous disorders |
WO2014160702A1 (en) | 2013-03-25 | 2014-10-02 | Chs Pharma, Inc. | Retinopathy treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5550124A (en) * | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
EP0757558A4 (en) * | 1994-04-12 | 1999-06-16 | Alza Corp | METHOD FOR DETECTING AGENTS THAT MODULATE AN INFLAMMATORY SKIN REACTION |
WO1996024358A1 (en) * | 1995-02-10 | 1996-08-15 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
WO2000010552A2 (en) * | 1998-08-24 | 2000-03-02 | Global Vascular Concepts, Inc. | Use of anti-angiogenic agents for inhibiting vessel wall injury |
UA74141C2 (uk) * | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
JP2004505060A (ja) * | 2000-07-27 | 2004-02-19 | ファルマシア・コーポレーション | 炎症関連心臓血管障害を防止するかまたは治療するためのアルドステロンアンタゴニストおよびシクロオキシゲナーゼ−2阻害剤併用療法 |
-
2003
- 2003-01-30 WO PCT/US2003/002923 patent/WO2003063908A1/en not_active Application Discontinuation
- 2003-01-30 PL PL03371436A patent/PL371436A1/pl not_active Application Discontinuation
- 2003-01-30 CA CA002473797A patent/CA2473797A1/en not_active Abandoned
- 2003-01-30 EP EP03706012A patent/EP1469884A1/en not_active Withdrawn
- 2003-01-30 KR KR10-2004-7011785A patent/KR20040078683A/ko not_active Application Discontinuation
- 2003-01-30 MX MXPA04007128A patent/MXPA04007128A/es not_active Application Discontinuation
- 2003-01-30 BR BR0307342-4A patent/BR0307342A/pt not_active IP Right Cessation
- 2003-01-30 JP JP2003563597A patent/JP2005521665A/ja not_active Withdrawn
- 2003-01-30 CN CNA038030330A patent/CN1625412A/zh active Pending
-
2004
- 2004-07-21 ZA ZA200405829A patent/ZA200405829B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003063908A1 (en) | 2003-08-07 |
CA2473797A1 (en) | 2003-08-07 |
CN1625412A (zh) | 2005-06-08 |
ZA200405829B (en) | 2005-10-21 |
MXPA04007128A (es) | 2005-03-31 |
EP1469884A1 (en) | 2004-10-27 |
BR0307342A (pt) | 2004-12-21 |
KR20040078683A (ko) | 2004-09-10 |
JP2005521665A (ja) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215265A1 (zh) | α相關疾病的治療 | |
EP1489915A4 (en) | TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS | |
HK1079203A1 (en) | Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders | |
PT2075000E (pt) | Combinação de azelastina e ciclesonida | |
IL162838A0 (en) | Compositions and methods for prevention and treatment peptide-of amyloid- related disorders | |
HK1073997A1 (en) | Administration of agents for the treatment of inflammation | |
AU2003213787A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
AU2003291480A8 (en) | Composition for the prevention and treatment of inflammation of the ear | |
IL145237A0 (en) | Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease | |
EP1406648A4 (en) | USE OF ANGIOTENSIN I DERIVATIVE AGENT FOR THE TREATMENT AND PREVENTION OF INFECTIOUS HEART DAMAGE AND DISEASES | |
GB0615918D0 (en) | Composition and its therapeutic use | |
PL371436A1 (pl) | Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
WO2002009759A3 (en) | Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders | |
AU2003250831A8 (en) | Use of hec1 antagonists in the treatment of proliferative disorders and cancer | |
EP1534293A4 (en) | INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
AU2003241346A8 (en) | Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer | |
IL164169A (en) | Non-steroidal progesterone receptor modulator compounds and their use in therapy | |
EP1539100A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS | |
AU2003270540A8 (en) | Treatment of cyclooxygenase-3 mediated diseases and disorders | |
PL373391A1 (pl) | Terapia blokerem aldosteronu w profilaktyce lub leczeniu zaburzeń związanych z zapaleniem | |
GB0419828D0 (en) | The treatment of inflammatroy disorders and pain | |
GB0305699D0 (en) | Therapeutic compositions and methods | |
EP1557169A4 (en) | THERAPEUTIC AND / OR PROPHYLACTIC AGENT FOR DYSCHEZIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |